Research ArticleNuclear Oncology
FDG PET: Elevated Plasma Glucose Reduces Both Uptake and Detection Rate of Pancreatic Malignancies
Christoph G. Diederichs, Ludger Staib, Gerhard Glatting, Hans Günther Beger and Sven Norbert Reske
Journal of Nuclear Medicine June 1998, 39 (6) 1030-1033;
Christoph G. Diederichs
Ludger Staib
Gerhard Glatting
Hans Günther Beger
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
FDG PET: Elevated Plasma Glucose Reduces Both Uptake and Detection Rate of Pancreatic Malignancies
Christoph G. Diederichs, Ludger Staib, Gerhard Glatting, Hans Günther Beger, Sven Norbert Reske
Journal of Nuclear Medicine Jun 1998, 39 (6) 1030-1033;
Jump to section
Related Articles
- No related articles found.
Cited By...
- [11C]Methionine PET vs. [18F]Fluorodeoxyglucose PET Whole-body Imaging to Determine the Extent of Methionine-addiction Compared to Glucose-addiction of Primary and Metastatic Cancer of the Trunk in Patients
- Assessing the Effect of Various Blood Glucose Levels on 18F-FDG Activity in the Brain, Liver, and Blood Pool
- Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients with Pancreatic Cancer
- Positron Emission Tomography/Computed Tomography for Diagnosis of Prosthetic Valve Endocarditis: Suggestions to Increase Diagnostic Accuracy
- Clinical Utility of 18F-FDG Positron Emission Tomography and Computed Tomography in Patients With Suspected Cardiovascular Implantable Electronic Device Infection
- In Vivo SPECT Imaging with 111In-DOTA-c(RGDfK) to Detect Early Pancreatic Cancer in a Hamster Pancreatic Carcinogenesis Model
- Need for Standardization of 18F-FDG PET/CT for Treatment Response Assessments
- Do Hyperglycemia and Diabetes Affect the Incidence of False-Negative 18F-FDG PET/CT Studies in Patients Evaluated for Infection or Inflammation and Cancer? A Comparative Analysis
- Measuring Response with FDG-PET: Methodological Aspects
- Impact of Intravenous Insulin on 18F-FDG PET in Diabetic Cancer Patients
- In Vivo Characterization of Proliferation for Discriminating Cancer from Pancreatic Pseudotumors
- Prosthetic Vascular Graft Infection: The Role of 18F-FDG PET/CT
- 18F-FDG PET and PET/CT in Fever of Unknown Origin
- Use of PET for Monitoring Cancer Therapy and for Predicting Outcome
- The Diabetic Foot: Initial Experience with 18F-FDG PET/CT
- Respiratory Gating for 3-Dimensional PET of the Thorax: Feasibility and Initial Results
- 18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies
- Performance of sodium iodide based 18F-fluorodeoxyglucose positron emission tomography in the characterization of indeterminate pulmonary nodules or masses
- Ki-67 Immunostaining in Pancreatic Cancer and Chronic Active Pancreatitis: Does In Vivo FDG Uptake Correlate with Proliferative Activity?
- Positron Emission Tomography Using [18F]-Fluorodeoxy-D-Glucose to Predict the Pathologic Response of Breast Cancer to Primary Chemotherapy